Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05939388 · ClinicalTrials.gov registry record · NA

Battlefield Auricular Acupressure (BAApress) Feasibility Study

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT05939388: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT05939388 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05939388, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

The purpose of this research study is to find out what effects (good and bad) acupressure applied to the outside of the ear (Auricular Acupressure), in addition to the standard of care medication regimen, will have on pain. This study is being done to assess whether acupressure in addition to prescribed pain medication may be of benefit in decreasing pain levels and improving overall wellbeing. This study will also evaluate the feasibility of routinely offering acupressure to patients having pain issues in addition to a psychiatric diagnosis.

Primary Outcome

Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

Interventions

  • DEVICE Auricular Acupressure Pads

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2023-11-14
Est. Completion 2024-03-01
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT05939388 record still lists

NCT05939388 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Auricular Acupressure Pads is the first listed.

NCT05939388 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05939388 about?

NCT05939388 is a clinical study titled "Battlefield Auricular Acupressure (BAApress) Feasibility Study". The purpose of this research study is to find out what effects (good and bad) acupressure applied to the outside of the ear (Auricular Acupressure), in addition to the standard of care medication regimen, will have on pain. This study is being done to assess whether acupressure in addition to prescr...

What is the current status of trial NCT05939388?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2023-11-14. Estimated completion is 2024-03-01.

What interventions are being tested in trial NCT05939388?

The interventions under investigation include: Auricular Acupressure Pads (DEVICE).

Who is sponsoring clinical trial NCT05939388?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05939388's enrollment target sits among peer trials

11 1927th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05939388, the US trial registry maintained by the National Library of Medicine. NCT05939388 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.